Role of a metastatic suppressor gene KAI1CD82 in the diagnosis and prognosis of breast cancer

Abstract EN

Globally, breast cancer is the most common type of cancer in females and is one of the leading causes of cancer death in women.

the advancement in the targeted therapies and the slight understanding of the molecular cascades of the disease have led to small improvement in the rate of survival of breast cancer patients.

however, metastasis and resistance to the current drugs still remain as challenges in the management of breast cancer patients.

metastasis, potentially, leads to failure of the available treatment, and thereby, makes the research on metastatic suppressors a high priority.

tumor metastasis suppressors are several genes and their protein products that have the capability of arresting the metastatic process without affecting the tumor formation.

the metastasis suppressors KAI1 (also known as CD82) has been found to inhibit tumor metastasis in various types of solid cancers, including breast cancer.

KAI1 was identified as a metastasis suppressor that inhibits the process of metastasis by regulating several mechanisms, including cell motility and invasion, induction of cell senescence, cell–cell adhesion and apoptosis.

KAI1 is a member of tetraspanin membrane protein family.

It interacts with other tetraspanins, chemokines and integrins to control diverse signaling pathways, which are crucial for protein trafficking and intracellular communication.

it follows that better understanding of the molecular events of such genes is needed to develop prognostic biomarkers, and to identify specific therapies for breast cancer patients.

this review aims to discuss the role of KAI1/CD82 as a prognosticator in breast cancer.